Back
Prenetics Global Vs. Monopar Therapeutics Industry Stock Comparison
Sell
25
PRE
Prenetics Global
Last Price:
$3.86
Seasonality Move:
-5.51%
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
Sell
25
Prenetics Global (PRE)
is a Sell
Is Prenetics Global a Buy, Sell or Hold?
-
The current Prenetics Global [PRE] share price is $4.00. The Score for PRE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
PRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRE Stock Price Chart
What is Prenetics Global's stock price today?
-
The Prenetics Global share price today is $4.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRE is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
PRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 32.88 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.11 - 4.99) | Sell |
Bollinger Bands (100): | (4.45 - 5.61) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | 2380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.07 - 39.49) | Buy |
Bollinger Bands (100): | (19.65 - 39.65) | Buy |
PRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.05 | Sell |
20-day SMA: | 4.4 | Sell |
50-day SMA: | 5.01 | Sell |
200-day SMA: | 5.12 | Sell |
8-day EMA: | 4.06 | Sell |
20-day EMA: | 4.36 | Sell |
50-day EMA: | 4.77 | Sell |
200-day EMA: | 5.39 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.86 | Buy |
20-day SMA: | 34.79 | Buy |
50-day SMA: | 37.86 | Buy |
200-day SMA: | 17.05 | Buy |
8-day EMA: | 38.75 | Buy |
20-day EMA: | 37.13 | Buy |
50-day EMA: | 35.15 | Buy |
200-day EMA: | 21.74 | Buy |
Prenetics Global Earnings Growth & PRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Prenetics Global Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |